Adoption of single agent anticancer therapy for advanced hepatocellular carcinoma and impact of facility type, insurance status, and income on survival: Analysis of the national cancer database 2004-2014.
Aman OpnejaGino CioffiAsrar AlahmadiNelroy JonesTin-Yun TangNirav PatilDavid L BajorJoel N SaltzmanAmr MohamedEva SelfridgeAnkit ManglaJill S Barnholtz-SloanRichard T LeePublished in: Cancer medicine (2021)
aHCC patients treated only with ACT have experienced an overall improvement in survival, but significant differences exist between facility type, insurance status, and income.